Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Heterogeneity of hepatitis delta antigen
1990
Natural history of hepatitis B
2003
Global epidemiology and genotype distribution of the hepatitis C virus infection
2014
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
2007
Hepatitis C Virus Infection
2001 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Sexual dimorphism of humoral immunity with human vaccines
2008
Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
2008
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants
2013
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection☆
2004
Detecting and characterizing circular RNAs
2014 Standout
Hepatitis B virus infection
2009 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Hepatitis D: Scenario in the Asia-Pacific region
2010
Severe Sepsis and Septic Shock
2013 Standout
Hepatitis B vaccines
2003
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
1997 Standout
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
1998
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
1990
Management of Hepatocellular Carcinoma *
2005 Standout
Global cancer statistics
2011 Standout
The Double-stranded RNA-activated Kinase, PKR, Can Phosphorylate Hepatitis D Virus Small Delta Antigen at Functional Serine and Threonine Residues
2002
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Human papillomavirus and cervical cancer
2007 Standout
Treating hepatitis C
2005 StandoutNobel
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
Educational Levels of Hospital Nurses and Surgical Patient Mortality
2003 Standout
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
2006
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Chapter 11: HPV vaccines: Commercial Research & Development
2006
Sex differences in immune responses
2016 Standout
Increased Incidence of Fulminant Hepatic Failure in Previously Unrecognized HBsAg Carriers with Acute Hepatitis Independent of Etiology
2005
Herpes Zoster
2013 Standout
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
2013
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
1997
Cancer as an evolutionary and ecological process
2006 Standout
Hepatocellular Carcinoma
2011 Standout
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
2015
Hepatocellular carcinoma
2022 Standout
Interferon-inducible antiviral effectors
2008 Standout
The use of antiviral agents for the management of severe influenza
2010
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta
1988 StandoutNobel
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
The hepatitis delta (δ) virus possesses a circular RNA
1986 Nature
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.
1984
Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
1983
Targeted therapy for uveal melanoma
2008
Clinical and Histological Events Preceding Hepatitis B e Antigen Seroconversion in Chronic Type B Hepatitis
1983
Radioimmunoassay detection of igm antibodies to the hbv‐associated delta (δ) antigen: Clinical significance in δ infection
1982
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Complementary Sequence-Mediated Exon Circularization
2014 Standout
TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUS
1985
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles
1997 StandoutNobel
Molecular and cellular signatures of human vaccine adjuvants
2008
The Delta Agent
1983
Neuroendocrine Tumor‐Targeted Upconversion Nanoparticle‐Based Micelles for Simultaneous NIR‐Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging
2017
Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s
1998 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
The effect of health care working conditions on patient safety.
2003
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
2015
Epidemiology and Clinical Impact of Hepatitis D Virus (Delta) Infection
1985
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Possible Viral Interactions in the Acquired Immunodeficiency Syndrome (AIDS)
1984
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
1998 StandoutScience
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Viral Hepatitis in Colombia: A Study of the “Hepatitis of the Sierra Nevada De Santa Marta”
1985
A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge
2007
Fulminant B Viral Hepatitis: Role of Delta Agent
1984
Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection
1987 StandoutNobel
Influence of Hepatitis Delta Virus Infection on Progression to Cirrhosis in Chronic Hepatitis Type B
1987
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
2003
Delta hepatitis — Present status
1985
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Works of P Dentico being referenced
Antifibrogenic Effect of IFN- α 2b on Hepatic Stellate Cell Activation by Human Hepatocytes
2006
Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients
1992
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma
2001
Long term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults
1992
Intra-Arterial Hepatic Chemoembolization in Liver Metastases from Neuroendocrine Tumors: A Phase II Study
2004
Long‐term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients
1996
Molecular characterisation of HCV genotype 4 isolates circulating in Italy
2000
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04
2004
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma
2005
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients
2007
Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age
2004
Prevalence of infected patients and understaffing have a rolein hepatitis C virus transmission in dialysis
2001
Hepatitis B Virus Infection in Health Care Workers in Albania: a Country still Highly Endemic for HBV Infection
2007
HBeAg/Anti-HBe System and Cell-Mediated Immunity in Patients with HBsAg-Positive Chronic Active Hepatitis
1980
INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B
1982
Infection with the Delta (δ) Agent in Chronic HBsAg Carriers
1981
Prevention of radiotherapy-induced emesis.
2003
Hepatitis B virus markers, alpha‐fetoprotein and survival in fulminant viral hepatitis
1981
CLINICAL SIGNIFICANCE OF ANTIBODY TO THE HEPATITIS DELTA VIRUS IN SYMPTOMLESS HBsAg CARRIERS
1985
EPIDEMIOLOGIC PATTERNS OF INFECTION WITH THE HEPATITIS B VIRUS-ASSOCIATED DELTA AGENT IN ITALY
1983
Familiar clustering and spreading of hepatitis delta virus infection
1985